Nanologica Future Growth
Future criteria checks 2/6
Nanologica is forecast to grow revenue at 95.5% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | 95.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 12 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 150 | N/A | N/A | N/A | 1 |
| 12/31/2025 | 90 | N/A | N/A | N/A | 1 |
| 12/31/2024 | 20 | N/A | N/A | N/A | 1 |
| 9/30/2024 | 9 | -88 | -66 | -59 | N/A |
| 6/30/2024 | 8 | -76 | -54 | -46 | N/A |
| 3/31/2024 | 8 | -80 | -61 | -49 | N/A |
| 12/31/2023 | 5 | -75 | -57 | -36 | N/A |
| 9/30/2023 | 6 | -53 | -59 | -42 | N/A |
| 6/30/2023 | 7 | -53 | -57 | -36 | N/A |
| 3/31/2023 | 7 | -51 | -51 | -34 | N/A |
| 12/31/2022 | 6 | -55 | -54 | -45 | N/A |
| 9/30/2022 | 5 | -56 | -55 | -49 | N/A |
| 6/30/2022 | 6 | -57 | -60 | -56 | N/A |
| 3/31/2022 | 9 | -53 | -61 | -58 | N/A |
| 12/31/2021 | 15 | -45 | -52 | -46 | N/A |
| 9/30/2021 | 21 | -35 | -48 | -44 | N/A |
| 6/30/2021 | 21 | -28 | -40 | -34 | N/A |
| 3/31/2021 | 21 | -23 | -45 | -39 | N/A |
| 12/31/2020 | 18 | -22 | -47 | -43 | N/A |
| 9/30/2020 | 14 | -24 | -47 | -33 | N/A |
| 6/30/2020 | 14 | -24 | -39 | -27 | N/A |
| 3/31/2020 | 14 | -23 | -48 | -16 | N/A |
| 12/31/2019 | 12 | -21 | -20 | -10 | N/A |
| 9/30/2019 | 12 | -18 | -11 | -9 | N/A |
| 6/30/2019 | 11 | -18 | -17 | -14 | N/A |
| 3/31/2019 | 8 | -19 | -14 | -11 | N/A |
| 12/31/2018 | 6 | -21 | -15 | -12 | N/A |
| 9/30/2018 | 7 | -18 | -26 | -24 | N/A |
| 6/30/2018 | 6 | -18 | N/A | -26 | N/A |
| 3/31/2018 | 5 | -19 | N/A | -21 | N/A |
| 12/31/2017 | 5 | -20 | N/A | -23 | N/A |
| 9/30/2017 | 3 | -22 | N/A | -17 | N/A |
| 6/30/2017 | 4 | -24 | N/A | -18 | N/A |
| 3/31/2017 | 4 | -24 | N/A | -24 | N/A |
| 12/31/2016 | 4 | -22 | N/A | -23 | N/A |
| 9/30/2016 | 5 | -23 | N/A | -25 | N/A |
| 6/30/2016 | 5 | -21 | N/A | -19 | N/A |
| 3/31/2016 | 7 | -18 | N/A | -17 | N/A |
| 12/31/2015 | 9 | -14 | N/A | -14 | N/A |
| 9/30/2015 | 8 | -14 | N/A | N/A | N/A |
| 6/30/2015 | 9 | -15 | N/A | N/A | N/A |
| 3/31/2015 | 7 | -14 | N/A | N/A | N/A |
| 12/31/2014 | 7 | -15 | N/A | N/A | N/A |
| 12/31/2013 | 5 | -10 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 4YD's forecast earnings growth is above the savings rate (1%).
Earnings vs Market: Insufficient data to determine if 4YD's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if 4YD's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 4YD's revenue (95.5% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 4YD's revenue (95.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 4YD's Return on Equity is forecast to be high in 3 years time